Report cover image

Diabetes Monitoring, Treatment and Drug Delivery Market Size, Share & Trends Analysis - United States - 2025-2031 - MedSuite - Includes: Insulin & GLP-1, Continuous Glucose Monitoring and 7 more

Publisher iData Research, Inc.
Published Feb 04, 2025
Length 236 Pages
SKU # IDR19639235

Description

The U.S. diabetes monitoring, treatment, and drug delivery market was valued at $48 billion in 2024 and is projected to grow at a CAGR of 7.3%, reaching $79 billion by 2031.

This report covers key market segments, including:

Blood Glucose Meters, Blood Glucose Test Strips, Lancets
Continuous Glucose Monitoring (CGM) & Flash Glucose Monitoring (FGM)
Insulin & GLP-1 Receptor Agonists (e.g., Ozempic®)
Insulin Pens, Insulin Syringes, and Insulin Pumps

Key Market Segment Insights

The largest and fastest-growing segment in 2024 was the insulin and GLP-1 receptor agonist market, which accounted for the majority of total market value. The growth of GLP-1 therapies is driven by:

Rising prevalence of type 2 diabetes and obesity
Increased demand for innovative treatment solutions
Advancements in therapies that address both diabetes and obesity
Market Data Highlights

The report includes:

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Market Drivers & Limiters
Market Forecasts Until 2031 and Historical Data from 2021
Competitive Analysis & Market Shares
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
U.S. Diabetes Market Trends
Smart Reusable Insulin Pens: The demand for smart insulin pens is increasing due to their ability to track doses, calculate insulin requirements, and provide reminders. These devices enhance diabetes management and offer greater convenience despite higher pricing.
Technological Advancements: Continuous improvements in CGM, insulin delivery systems, and digital health solutions are expected to drive the market forward.

Market Share Insights

Top Competitors in the U.S. Diabetes Market (2024):

1 Novo Nordisk

Market leader in insulin and second in insulin pens.
Top position in ultra-long-acting & ultra-rapid-acting insulin.
Only competitor in the rapid-acting insulin market.
GLP-1 portfolio includes Ozempic®, Rybelsus®, and Xultophy®.

2 Eli Lilly

Second-largest competitor in the insulin market.
Leader in premixed insulin, ultra-rapid-acting insulin, and human insulin.
GLP-1 portfolio includes Trulicity®, Mounjaro®, and Zepbound®.

3 Dexcom

Dominates the continuous glucose monitoring (CGM) market.
Strong sales from G6® (FDA approval in 2018) and G7 (FDA approval in 2023).

Market Segmentation Summary

This report suite includes all relevant market data, but individual MedCore reports are available for specific segments.

Blood Glucose Meter Market
Segmented Into: Personal & Professional
Blood Glucose Test Strip Market
Segmented Into: Personal & Professional
Lancet Market
Segmented Into: Personal & Professional
Continuous Glucose Monitoring (CGM) Market
Segmented Into: Personal & Professional
Flash Glucose Monitoring (FGM) Market
Segmented Into: Readers & Sensors
Insulin and GLP-1 Market
Insulin Types: Long-Acting, Ultra-Long-Acting, Rapid-Acting, Ultra-Rapid-Acting, Premixed, Human
GLP-1 Segments:
Diabetes Care: GLP-1 Injection, GLP-1 Oral
Obesity Care: GLP-1 Injection
Insulin Pen Market
Segmented Into: Reusable Pens & Pen Needles
Insulin Syringe Market
Segmented Into: Conventional & Safety Syringes
Insulin Pump Market
Segmented Into: Durable, Patch, and Simple Pumps
Global Research Scope

Report Attributes and Details:

Region: United States
Base Year: 2024
Forecast Period: 2025-2031
Historical Data: 2021-2023

Quantitative Coverage:

Market Size, Market Shares, Market Forecasts, Growth Rates
Units Sold, Average Selling Prices

Qualitative Coverage:

COVID-19 Impact
Market Trends & Limiters
Competitive Analysis & SWOT for Leading Competitors
Mergers & Acquisitions
Company Profiles & Product Portfolios
FDA Recalls & Disruptive Technologies
Disease Overviews

Data Sources:

Industry Leader Interviews
Government & Regulatory Data
Hospital & Private Sector Data
Import & Export Records
iData Research Internal Database

Table of Contents

236 Pages
Executive Summary
U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
Competitive Analysis
Emerging Markets and Technologies
Market Developments
Market Trends
Market Segmentation
Key Report Updates
Version History
research methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
2.1.4 Signs and Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
U.S. Diabetes Monitoring, Treatment and Drug Delivery Market Overview
3.1 Introduction
3.2 Market Overview & Trend Analysis
3.3 Drivers and Limiters
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers and Acquisitions
patient demographics AND INSTALLED BASE
4.1 Patient Demographics
4.1.1 Diagnosed Diabetes Patient Population by Type
4.1.2 Diagnosed Type 2 Diabetes Patient Population by Type
4.1.3 Diagnosed Insulin-Dependent Diabetes Patient Population by Type
4.2 Installed Base Analysis and Forecast
4.2.1 Personal Glucose Monitoring Installed Base by Segment
4.2.2 Personal CGM Installed Base by Patient Type
4.2.3 Insulin User Installed Base by Segment
4.2.4 Durable Pump Installed Base by Diabetes Type
4.2.5 Patch Pump Installed Base by Diabetes Type
4.2.6 MDI Installed Base by Segment
4.2.7 MDI Installed Base by Diabetes Type
Blood glucose meter Market
5.1 Introduction
5.2 Market Overview
5.3 Market Analysis and Forecast
5.3.1 Personal Blood Glucose Meter Market
5.3.2 Professional Blood Glucose Meter Market
5.4 Drivers and Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
Blood Glucose test strip Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Total Blood Glucose Test Strip Market
6.3.2 Personal Blood Glucose Test Strip Market
6.3.2.1 Medicare/Medicaid Personal Blood Glucose Test Strip Market
6.3.2.2 Managed Care Personal Blood Glucose Test Strip Market
6.3.2.3 Personal Cash Blood Glucose Test Strip Market
6.3.3 Professional Blood Glucose Test Strip Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis
Lancet Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Lancet Market
7.3.2 Personal Lancet Market
7.3.3 Professional Lancet Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis
Continuous Glucose MonitorinG Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Personal Continuous Glucose Monitoring Market
8.3.1.1 Personal Continuous Glucose Monitoring Receiver Market
8.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market
8.3.1.3 Personal Continuous Glucose Monitoring Sensor Market
8.3.2 Professional Continuous Glucose Monitoring Market
8.3.2.1 Professional Continuous Glucose Monitoring System Market
8.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market
8.3.2.3 Professional Continuous Glucose Monitoring Sensor Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis
8.5.1 Continuous Glucose Monitoring Market Installed Base Share
Flash Glucose monitoring Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Flash Glucose Monitoring Reader Market
9.3.2 Flash Glucose Monitoring Sensor Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis
Insulin and GLP-1 Market
10.1 Introduction
10.1.1 Insulin Types
10.1.1.1 Rapid-Acting Insulin Analog
10.1.1.2 Ultra-Rapid-Acting Insulin Analog
10.1.1.3 Regular Human Insulin
10.1.1.4 Intermediate-Acting Human Insulin
10.1.1.5 Long-Acting Insulin Analog
10.1.1.6 Ultra-Long-Acting Insulin Analog
10.1.1.7 Premixed Insulin
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Insulin Market
10.3.1.1 Long-Acting Insulin Market
10.3.1.2 Ultra-Long-Acting Insulin Market
10.3.1.3 Rapid-Acting Insulin Market
10.3.1.4 Ultra-Rapid-Acting Insulin Market
10.3.1.5 Premixed Insulin Market
10.3.1.6 Human Insulin Market
10.3.2 GLP-1 Market
10.3.2.1 GLP-1 Diabetes Care Injection Market
10.3.2.2 GLP-1 Diabetes Care Oral Market
10.3.2.3 GLP-1 Obesity Care Injection Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis
Insulin pen Market
11.1 Introduction
11.2 Market Overview
11.3 Market Analysis and Forecast
11.3.1 Reusable Pen Market
11.3.1.1 Standard Reusable Pen Market
11.3.1.2 Smart Reusable Pen Market
11.3.2 Pen Needle Market
11.3.2.1 Conventional Pen Needle Market
11.3.2.2 Safety Pen Needle Market
11.4 Drivers and Limiters
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 Competitive Market Share Analysis
Insulin Syringe Market
12.1 Introduction
12.2 Market Overview
12.3 Market Analysis and Forecast
12.3.1 Total Insulin Syringe Market
12.3.2 Conventional Insulin Syringe Market
12.3.3 Safety Insulin Syringe Market
12.4 Drivers and Limiters
12.4.1 Market Drivers
12.4.2 Market Limiters
12.5 Competitive Market Share Analysis
Insulin pump Market
13.1 Introduction
13.1.1 Durable Insulin Pumps
13.1.2 Patch Insulin Pumps
13.1.3 Simple Insulin Pumps
13.2 Market Overview
13.3 Market Analysis and Forecast
13.3.1 Durable Insulin Pump Market
13.3.1.1 Durable Pump Market
13.3.1.2 Infusion Set Market
13.3.1.3 Pump Reservoir Market
13.3.2 Patch Insulin Pump Market
13.3.2.1 Patch Pump System Market
13.3.2.2 Insulin Pod Market
13.3.3 Simple Insulin Pump Market
13.4 Drivers and Limiters
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 Competitive Market Share Analysis
13.5.1 Durable Insulin Pump Market
13.5.2 Insulin Pump Market Installed Base Share
Abbreviations
List of Charts
Chart 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2024 – 2031
Chart 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2024 & 2031
Chart 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 – 2031
Chart 3-2: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2024
Chart 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 – 2031
Chart 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 – 2031
Chart 5-2: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
Chart 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 – 2031
Chart 6-2: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
Chart 7-1: Lancet Market by Segment, U.S., 2021 – 2031
Chart 7-2: Leading Competitors, Lancet Market, U.S., 2024
Chart 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031
Chart 8-2: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
Chart 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 – 2031
Chart 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 – 2031
Chart 10-2: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
Chart 11-1: Insulin Pen Market by Segment, U.S., 2021 – 2031
Chart 11-2: Leading Competitors, Insulin Pen Market, U.S., 2024
Chart 12-1: Insulin Syringe Market by Segment, U.S., 2021 – 2031
Chart 12-2: Leading Competitors, Insulin Syringe Market, U.S., 2024
Chart 13-1: Insulin Pump Market by Segment, U.S., 2021 – 2031
Chart 13-2: Leading Competitors, Insulin Pump Market, U.S., 2024
List of Figures
Figure 1-1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (1 of 2)
Figure 1-2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2024 (2 of 2)
Figure 1-3: Companies Researched in this Report, U.S., 2024 (1 of 2)
Figure 1-4: Companies Researched in this Report, U.S., 2024 (2 of 2)
Figure 1-5: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 – 2024 (1 of 2)
Figure 1-6: Recent Events in the Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2019 – 2024 (2 of 2)
Figure 1-7: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (1 of 2)
Figure 1-8: Factors Impacting the Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S. (2 of 2)
Figure 1-9: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (1 of 2)
Figure 1-10: Diabetes Monitoring, Treatment, and Drug Delivery Market Segmentation (2 of 2)
Figure 1-11: Patient Demographics and Installed Base Segmentation
Figure 1-12: Key Report Updates
Figure 1-13: Version History
Figure 3-1: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 – 2031 (US$M) (1 of 2)
Figure 3-2: Diabetes Monitoring, Treatment, and Drug Delivery Market by Segment, U.S., 2021 – 2031 (US$M) (2 of 2)
Figure 3-3: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (1 of 2)
Figure 3-4: Leading Competitors, Diabetes Monitoring, Treatment, and Drug Delivery Market, U.S., 2024 (2 of 2)
Figure 4-1: Diagnosed Diabetes Patient Population by Type, U.S., 2021 – 2031
Figure 4-2: Diagnosed Type 2 Diabetes Patient Population by Type, U.S., 2021 – 2031
Figure 4-3: Diagnosed Insulin-Dependent Diabetes Patient Population by Type, U.S., 2021 – 2031
Figure 4-4: Glucose Monitoring Installed Base by Segment, U.S., 2021 – 2031
Figure 4-5: Personal CGM Installed Base by Patient Type, U.S., 2021 – 2031
Figure 4-6: Insulin User Installed Base by Segment, U.S., 2021 – 2031
Figure 4-7: Durable Pump Installed Base by Diabetes Type, U.S., 2021 – 2031
Figure 4-8: Patch Pump Installed Base by Diabetes Type, U.S., 2021 – 2031
Figure 4-9: MDI Installed Base by Segment, U.S., 2021 – 2031
Figure 4-10: MDI Installed Base by Diabetes Type, U.S., 2021 – 2031
Figure 5-1: Blood Glucose Meter Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 5-2: Personal Blood Glucose Meter Market, U.S., 2021 – 2031
Figure 5-3: Professional Blood Glucose Meter Market, U.S., 2021 – 2031
Figure 5-4: Leading Competitors, Blood Glucose Meter Market, U.S., 2024
Figure 6-1: Blood Glucose Test Strip Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 6-2: Total Blood Glucose Test Strip Market, U.S., 2021 – 2031
Figure 6-3: Personal Blood Glucose Test Strip Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 6-4: Total Personal Blood Glucose Test Strip Market, U.S., 2021 – 2031
Figure 6-5: Medicare/Medicaid Personal Blood Glucose Test Strip Market, U.S., 2021 – 2031
Figure 6-6: Managed Care Personal Blood Glucose Test Strip Market, U.S., 2021 – 2031
Figure 6-7: Personal Cash Blood Glucose Test Strip Market, U.S., 2021 – 2031
Figure 6-8: Professional Blood Glucose Test Strip Market, U.S., 2021 – 2031
Figure 6-9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2024
Figure 7-1: Lancet Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 7-2: Total Lancet Market, U.S., 2021 – 2031
Figure 7-3: Personal Lancet Market, U.S., 2021 – 2031
Figure 7-4: Professional Lancet Market, U.S., 2021 – 2031
Figure 7-5: Leading Competitors, Lancet Market, U.S., 2024
Figure 8-1: Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 8-2: Personal Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 8-3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2021 – 2031
Figure 8-4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2021 – 2031
Figure 8-5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2021 – 2031
Figure 8-6: Professional Continuous Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 8-7: Professional Continuous Glucose Monitoring System Market, U.S., 2021 – 2031
Figure 8-8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2021 – 2031
Figure 8-9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2021 – 2031
Figure 8-10: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2024
Figure 8-11: Leading Competitors, Continuous Glucose Monitoring Market Installed Base Share, U.S., 2024
Figure 9-1: Flash Glucose Monitoring Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 9-2: Flash Glucose Monitoring Reader Market, U.S., 2021 – 2031
Figure 9-3: Flash Glucose Monitoring Sensor Market, U.S., 2021 – 2031
Figure 9-4: Leading Competitors, Flash Glucose Monitoring Market, U.S., 2024
Figure 10-1: Insulin and GLP-1 Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 10-2: Insulin Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 10-3: Total Insulin Market, U.S., 2021 – 2031
Figure 10-4: Long-Acting Insulin Market, U.S., 2021 – 2031
Figure 10-5: Ultra-Long-Acting Insulin Market, U.S., 2021 – 2031
Figure 10-6: Rapid-Acting Insulin Market, U.S., 2021 – 2031
Figure 10-7: Ultra-Rapid-Acting Insulin Market, U.S., 2021 – 2031
Figure 10-8: Premixed Insulin Market, U.S., 2021 – 2031
Figure 10-9: Human Insulin Market, U.S., 2021 – 2031
Figure 10-10: GLP-1 Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 10-11: Total GLP-1 Market, U.S., 2021 – 2031
Figure 10-12: GLP-1 Diabetes Care Injection Market, U.S., 2021 – 2031
Figure 10-13: GLP-1 Diabetes Care Oral Market, U.S., 2021 – 2031
Figure 10-14: GLP-1 Obesity Care Injection Market, U.S., 2021 – 2031
Figure 10-15: Leading Competitors, Insulin and GLP-1 Market, U.S., 2024
Figure 10-16: Leading Competitors, Insulin Market, U.S., 2024
Figure 10-17: Leading Competitors, GLP-1 Market, U.S., 2024
Figure 11-1: Insulin Pen Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 11-2: Reusable Pen Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 11-3: Total Reusable Pen Market, U.S., 2021 – 2031
Figure 11-4: Standard Reusable Pen Market, U.S., 2021 – 2031
Figure 11-5: Smart Reusable Pen Market, U.S., 2021 – 2031
Figure 11-6: Pen Needle Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 11-7: Total Pen Needle Market, U.S., 2021 – 2031
Figure 11-8: Conventional Pen Needle Market, U.S., 2021 – 2031
Figure 11-9: Safety Pen Needle Market, U.S., 2021 – 2031
Figure 11-10: Leading Competitors, Insulin Pen Market, U.S., 2024
Figure 12-1: Insulin Syringe Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 12-2: Total Insulin Syringe Market, U.S., 2021 – 2031
Figure 12-3: Total Conventional Insulin Syringe Market, U.S., 2021 – 2031
Figure 12-4: Safety Insulin Syringe Market, U.S., 2021 – 2031
Figure 12-5: Leading Competitors, Insulin Syringe Market, U.S., 2024
Figure 13-1: Insulin Pump Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 13-2: Durable Insulin Pump Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 13-3: Durable Pump Market, U.S., 2021 – 2031
Figure 13-4: Infusion Set Market, U.S., 2021 – 2031
Figure 13-5: Pump Reservoir Market, U.S., 2021 – 2031
Figure 13-6: Patch Insulin Pump Market by Segment, U.S., 2021 – 2031 (US$M)
Figure 13-7: Patch Pump System Market, U.S., 2021 – 2031
Figure 13-8: Insulin Pod Market, U.S., 2021 – 2031
Figure 13-9: Simple Insulin Pump Market, U.S., 2021 – 2031
Figure 13-10: Leading Competitors, Insulin Pump Market, U.S., 2024
Figure 13-11: Leading Competitors, Durable Insulin Pump Market, U.S., 2024
Figure 13-12: Leading Competitors, Insulin Pump Market Installed Base Share, U.S., 2024

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us